Welcome to Medications.com

BioAlliance Pharma Announces a 786% Increase in Revenues for the ... - Nanowerk LLC

With regard to acyclovir Lauriad® in the treatment of recurrent oral herpes, the company has extended its international phase III trial to the United States ...

http://www.nanowerk.com/news/news... | Posted: Wed Jan 30 12:43:29 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea